CliffBio
small molecule

EPIOXA HD/EPIOXA KIT

RIBOFLAVIN 5'-PHOSPHATE SODIUM

Loss of exclusivityOctober 2028FDA regulatory exclusivity expiry
CompanyGlaukos →View the full company profile on CliffBio

Drug detail

Brand nameEPIOXA HD/EPIOXA KIT
Active ingredientRIBOFLAVIN 5'-PHOSPHATE SODIUM
StrengthEQ 0.239% BASE/ML;EQ 0.177% BASE/ML
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalOctober 2025
Marketing statusRX

Regulatory exclusivity

CodeExpires
NPOctober 2028

More from Glaukos

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.

EPIOXA HD/EPIOXA KIT patent cliff — loss of exclusivity October 2028 | CliffBio